ARO-C3 is an investigational RNA interference therapeutic designed to reduce liver production of complement component 3 as a potential therapy for various complement-mediated diseases.

Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, explains that sequencing novel multiple myeloma therapies with CAR T-cell therapy is generally prioritized first for eligible patients, ...

The use of Bloom filters in network applications has increased rapidly. Since Bloom filters can produce false positives, the trueness of each positive needs to be identified by referring to an ...

The 2025 Chevrolet Suburban offers more space than any other eight-seat SUV with 144.5 cubic feet of cargo volume available.

In recent years, provenance graph-based methods have gained widespread usage in system threat detection. However, the sheer volume of data within system logs poses significant challenges for the ...